USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India
USV Pvt. Ltd, leaders in oral anti-diabetes segment, has announced the launch of 1st biosimilar Insulin Aspart in India, INSUQUICK, for the treatment of people living with Diabetes
INSUQUICK® is DCGI-approved for the management of glycemic control in people living with Diabetes.
INSUQUICK® is available in INSUQUICK® Cartridge, INSUQUICK® vial & INSUQUICK® VDPen.
INSUQUICK® VDPen is a prefilled, disposable variable dose pen injector, featuring a modern robust design, lightweight, large legible scale, and with audible clicks for precise incremental settings.
USV has also announced the launch of USVPen®, a reusable pen designed for USV’s range of insulin. USVPen® delivers accurate dose of insulin with low dose force which makes it user-friendly.
Achieved through relentless R&D efforts of more than 10 years, INSUQUICK® uses 100% indigenous robust technology, guaranteeing complete cold chain care. INSUQUICK® aligns with global regulatory standards, making it a world-class and truly "Made in India" affordable solution.
Insuquick establishes fingerprint-like similarity in efficacy, safety, and immunogenicity profile as compared to Innovator.
Disclaimer: This post has been published under MD Brand Connect Initiative and is sponsored by USV Private Limited.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.